Vitamin D level could predict severity of COVID-19 effectively
In a recent study from Trinity College Dublin, scientists found that vitamin D can determine the severity of COVID-19, and they are calling on...
Long COVID affects 23% of patients and symptoms may last months
Scientists from the University of Southern California found that 23% of people infected with COVID will become "long haulers," and identifies predictors of who...
Is e-cigarette a healthier choice for smokers? Not necessarily
Some studies have suggested electronic cigarette, or EC, use may be a healthier alternative to cigarette smoking.
A University of California, Riverside, study shows this...
This test can detect COVID-19 infection and severity very fast
In a recent study from George Washington University, scientists developed a blood test that quickly detects if someone has COVID-19 and predicts how severely...
These people 5 times more likely to get COVID-19
In a recent study from Clalit Health Services, scientists found after people have recovered from COVID-19, getting at least one dose of a vaccine...
Don’t use these two drugs for mild COVID-19, WHO says
Scientists from WHO suggest that the antidepressant drug fluvoxamine and the gout drug colchicine are not recommended for patients with mild or moderate COVID-19.
This...
Big differences between mild and severe COVID-19
In a recent study from La Jolla Institute for Immunology, researchers found big differences between mild vs. severe COVID-19 cases.
They found that people with...
33% of older COVID survivors develop new diseases after infection
Scientists found almost a third (32 of every 100) of older adults infected with COVID-19 developed at least one new condition in the months...
Why some people have lower COVID-19 infection from omicron
Since the beginning of the COVID-19 pandemic, SARS-CoV-2 has continued to evolve, with new variants of concern (VoCs) spreading rapidly.
omicron has become the dominant...
This antibody treatment could lower death risk in severe COVID-19
Scientists from Duke University found a monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths.
The...